Uma Mahadevan, MD
|
| Title | Associate Professor of Clinical |
|---|
| School | UCSF School of Medicine |
|---|
| Department | Medicine |
|---|
| Address | 2330 Post Street San Francisco CA 94115
|
|---|
| Phone | 415-502-4444 |
|---|
|
|
Biography | 2008
-
| 2011 | Best Doctors in America |
Overview Active Projects: • Pregnancy Outcomes in Women with IBD: PIANO – national pregnancy registry • Genetic, environmental and serologic characteristics of South Asians with IBD • Clinical Trials in Inflammatory Bowel Disease • Levels of drug and outcomes in IBD • Healthcare maintenance in IBD Techniques in Use: • Endoscopy • Colonoscopy Education • 1987-1991 University of California, Los Angeles, Bachelor of Science, Biology, Cum Laude, o College of Honors • 1991-1995 Medical School, State University of New York, Brooklyn, Doctor of Medicine Training • 1995-1998 Residency, Internal Medicine, Mount Sinai Medical Center • 1998-2001 Fellowship, Gastroenterology, University of California, San Francisco • 2000-2001 Inflammatory Bowel Diseases Fellowship, Mayo Clinic, Rochester, MN Certification • American Board of Internal Medicine, Diplomate in Gastroenterology 2001, 2011 • American Board of Internal Medicine, Diplomate in Internal Medicine 1998 • United States Medical Licensing Exam Memberships and Affiliations • American Gastroenterological Association 1998-present o IMIBD Counselor • American College of Gastroenterology 2000-present • Crohn’s and Colitis Foundation of America 2000-present o CCFA National Patient Education Committee 2003-present o Chairman, Patient Education 2005-2008 o National Scientific Advisory Committee 2005-2008 o Executive Board, Bay Area Chapter 2001-2003 • Northern California Society of Clinical Gastroenterology 2002-present o President 2005 • We Care in IBD 2004-present o Patient Education Officer 2006-present • Asian American Research Center on Health Core Member
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Ng SW, Mahadevan U. Management of inflammatory bowel disease in pregnancy. Expert Rev Clin Immunol. 2013 Feb; 9(2):161-74.
-
Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS. Systematic Review and Meta-analysis on the Effects of Thiopurines on Birth Outcomes from Female and Male Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2013 Jan; 19(1):15-22.
-
Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):286-92.
-
Pak S, Holland N, Garnett EA, Mileti E, Mahadevan U, Beckert R, Kanwar B, Heyman MB. Cytokine profiles in peripheral blood of children and adults with Crohn disease. J Pediatr Gastroenterol Nutr. 2012 Jun; 54(6):769-75.
-
Hwang C, Ross V, Mahadevan U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm Bowel Dis. 2012 Oct; 18(10):1961-81.
-
Sheibani S, Mahadevan U. Editorial: Are Thiopurines and Anti-TNFa Agents Safe to Use in Pregnant Patients With Inflammatory Bowel Disease? Am J Gastroenterol. 2012 Mar; 108(3):441-3.
-
Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A, Fernández-Bañares F. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis. 2011 Dec; 5(6):612-8.
-
Leung Y, Heyman MB, Mahadevan U. Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist. Inflamm Bowel Dis. 2011 Oct; 17(10):2169-73.
-
Mahadevan U, Cucchiara S, Hyams JS, Steinwurz F, Nuti F, Travis SP, Sandborn WJ, Colombel JF. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol. 2011 Feb; 106(2):214-23; quiz 224.
-
Broadhurst MJ, Leung JM, Kashyap V, McCune JM, Mahadevan U, McKerrow JH, Loke P. IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med. 2010 Dec 1; 2(60):60ra88.
-
van der Woude CJ, Kolacek S, Dotan I, Oresland T, Vermeire S, Munkholm P, Mahadevan U, Mackillop L, Dignass A. European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis. 2010 Nov; 4(5):493-510.
-
Kwan LY, Mahadevan U. Inflammatory bowel disease and pregnancy: an update. Expert Rev Clin Immunol. 2010 Jul; 6(4):643-57.
-
Dotan I, Rachmilewitz D, Schreiber S, Eliakim R, van der Woude CJ, Kornbluth A, Buchman AL, Bar-Meir S, Bokemeyer B, Goldin E, Maaser C, Mahadevan U, Seidler U, Hoffman JC, Homoky D, Plasse T, Powers B, Rutgeerts P, Hommes D. A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease. Gut. 2010 Jun; 59(6):760-6.
-
Hou JK, Velayos F, Terrault N, Mahadevan U. Viral hepatitis and inflammatory bowel disease. Inflamm Bowel Dis. 2010 Jun; 16(6):925-32.
-
El-Nachef N, Terdiman J, Mahadevan U. Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation. Am J Gastroenterol. 2010 May; 105(5):1210-1.
-
Baumgart DC, Targan SR, Dignass AU, Mayer L, van Assche G, Hommes DW, Hanauer SB, Mahadevan U, Reinisch W, Plevy SE, Salzberg BA, Buchman AL, Mechkov GM, Krastev ZA, Lowder JN, Frankel MB, Sandborn WJ. Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis. 2010 Apr; 16(4):620-9.
-
Molloy JW, Kim E, Mahadevan U. Do side-by-side anastomoses decrease the risk of recurrence in Crohn's disease? Gastroenterology. 2010 May; 138(5):2010-2.
-
Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S. Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis. Gastroenterology. 2010 Apr; 138(4):1286-96, 1296.e1-3.
-
Mahadevan U. Pregnancy and inflammatory bowel disease. Med Clin North Am. 2010 Jan; 94(1):53-73.
-
Mahadevan U, Kane S. Use of infliximab in pregnancy. Am J Gastroenterol. 2010 Jan; 105(1):219; author reply 219-20.
-
Mahadevan U. Pregnancy and inflammatory bowel disease. Gastroenterol Clin North Am. 2009 Dec; 38(4):629-49.
-
Sewell JL, Mahadevan U. Of blemishes and bowels: isotretinoin and inflammatory bowel disease. Gastroenterology. 2010 Jan; 138(1):392-4.
-
Mahadevan U. Cervical neoplasia risk in IBD: truth or hysteria? Inflamm Bowel Dis. 2009 Nov; 15(11):1619-20.
-
Moscandrew M, Mahadevan U, Kane S. General health maintenance in IBD. Inflamm Bowel Dis. 2009 Sep; 15(9):1399-409.
-
McCabe JM, Mahadevan U, Vidyarthi A. An obscure harbinger. Difficult diagnosis of Crohn's Disease. Am J Med. 2009 Jun; 122(6):516-8.
-
Sewell JL, Mahadevan U. A new answer to an old question: azathioprine withdrawal in quiescent Crohn's disease. Gastroenterology. 2009 Jul; 137(1):379-81.
-
Hou JK, Mahadevan U. A 24-year-old pregnant woman with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2009 Sep; 7(9):944-7.
-
Costouros NG, Niho H, Mahadevan U, Kerlan RK, Bloom AI. Angiographic embolization for control of life-threatening hemorrhage from benign rectal ulcers. J Vasc Interv Radiol. 2009 Apr; 20(4):561-2.
-
Thia KT, Mahadevan U, Feagan BG, Wong C, Cockeram A, Bitton A, Bernstein CN, Sandborn WJ. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2009 Jan; 15(1):17-24.
-
Sewell JL, Mahadevan U. Infliximab and surgical complications: truth or perception? Gastroenterology. 2009 Jan; 136(1):354-5.
-
Dubinsky M, Abraham B, Mahadevan U. Management of the pregnant IBD patient. Inflamm Bowel Dis. 2008 Dec; 14(12):1736-50.
-
Mahadevan U. Continuing immunomodulators and biologic medications in pregnant IBD patients - pro. Inflamm Bowel Dis. 2007 Nov; 13(11):1439-40.
-
Plevy S, Salzberg B, Van Assche G, Regueiro M, Hommes D, Sandborn W, Hanauer S, Targan S, Mayer L, Mahadevan U, Frankel M, Lowder J. A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology. 2007 Nov; 133(5):1414-22.
-
Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007 Oct; 133(4):1106-12.
-
Velayos F, Mahadevan U. Management of steroid-dependent ulcerative colitis: immunomodulatory agents, biologics, or surgery? Clin Gastroenterol Hepatol. 2007 Jun; 5(6):668-71.
-
Mahadevan U. TNF-alpha antagonists: benefits beyond remission. Rev Gastroenterol Disord. 2007; 7 Suppl 1:S13-9.
-
Mahadevan U. Gastrointestinal medications in pregnancy. Best Pract Res Clin Gastroenterol. 2007; 21(5):849-77.
-
Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut. 2006 Aug; 55(8):1198-206.
-
Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006 Jul; 131(1):283-311.
-
Mahadevan U, Kane S. American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006 Jul; 131(1):278-82.
-
Mahadevan U. Mucosal healing in Crohn's disease: what you see is what you get? Gastrointest Endosc. 2006 Mar; 63(3):443-4.
-
Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut. 2005 Jun; 54(6):890.
-
Mahadevan U, Terdiman JP, Aron J, Jacobsohn S, Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis. 2005 Apr; 11(4):395-9.
-
Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, Binion DG. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther. 2005 Mar 15; 21(6):733-8.
-
Gill KR, Mahadevan U. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease. Inflamm Bowel Dis. 2005 Feb; 11(2):210-2.
-
Mahadevan U. Medical treatment of ulcerative colitis. Clin Colon Rectal Surg. 2004 Feb; 17(1):7-19.
-
Mahadevan U, Marion JF, Present DH. Fistula response to methotrexate in Crohn's disease: a case series. Aliment Pharmacol Ther. 2003 Nov 15; 18(10):1003-8.
-
Mahadevan U. 6TG: when less is more than you bargained for. Inflamm Bowel Dis. 2003 Nov; 9(6):394-5.
-
Mathy C, Schneider K, Chen YY, Varma M, Terdiman JP, Mahadevan U. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm Bowel Dis. 2003 Nov; 9(6):351-5.
-
Mahadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology. 2003 May; 124(6):1636-50.
-
Mahadevan U, Loftus EV, Tremaine WJ, Pemberton JH, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflamm Bowel Dis. 2002 Sep; 8(5):311-6.
-
Mahadevan U, Loftus EV, Tremaine WJ, Sandborn WJ. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. Am J Gastroenterol. 2002 Apr; 97(4):910-4.
-
Mahadevan U, Sandborn WJ. Evolving medical therapies for Crohn's disease. Curr Gastroenterol Rep. 2001 Dec; 3(6):471-6.
-
Mahadevan U, Sandborn WJ. Infliximab for the treatment of orofacial Crohn's disease. Inflamm Bowel Dis. 2001 Feb; 7(1):38-42.
-
Mahadevan U, Tremaine WJ, Johnson T, Pike MG, Mays DC, Lipsky JJ, Sandborn WJ. Intravenous azathioprine in severe ulcerative colitis: a pilot study. Am J Gastroenterol. 2000 Dec; 95(12):3463-8.
|
Uma's Networks
Click the "See All" links for more information and interactive visualizations!
Related Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share similar concepts with this person. _
|